TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
88.24
+19.26 (27.92%)
At close: Nov 6, 2026, 4:00 PM EST
88.00
-0.24 (-0.27%)
After-hours: Nov 6, 2026, 7:58 PM EST

TransMedics Group Revenue

TransMedics Group had revenue of $203.01M in the quarter ending September 30, 2026, with 41.15% growth. This brings the company's total for the last twelve months to $727.65M, up 28.48% year-over-year. In the year 2025, TransMedics Group had annual revenue of $605.49M with 37.13% growth. That makes TransMedics Group the 9,208th largest company in the world by revenue and 2,042nd in the United States.

Revenue (ttm)
$727.65M
Revenue Growth
+28.48%
P/S Ratio
4.21
Revenue / Employee
$810,301
Employees
898
Market Cap
3.06B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • United States Liver 459.42M 75.9%
  • United States Heart 111.84M 18.5%
  • All Other Countries Heart 14.17M 2.3%
  • United States Lung 13.44M 2.2%
  • Other Service 4.10M 0.7%
  • All Other Countries Lung 1.42M 0.2%
  • All Other Countries Liver 1.11M 0.2%

By Geography

  • United States 584.70M 97.2%
  • ALL Other Countries 16.70M 2.8%
Fiscal year ended Dec 31, 2025 See the full TransMedics Group breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025605.49M163.95M37.13%
Dec 31, 2024441.54M199.92M82.74%
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 202025.64M2.04M8.62%
Dec 28, 201923.60M10.59M81.33%
Dec 31, 201813.02M5.33M69.38%
Dec 30, 20177.69M-5.33M-40.96%
Dec 31, 201613.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Integer Holdings1.83B
LivaNova1.51B
Haemonetics1.38B
Neogen884.00M
Inspire Medical Systems880.94M
iRhythm Holdings854.04M
UFP Technologies649.52M
Axogen266.93M
Revenue Rankings